Patient-Reported Outcomes Are More Important Than Objective Inflammatory Markers for Sick Leave in Biologics-Treated Patients With Rheumatoid Arthritis
Tor Olofsson, Jonas K Söderling, Anders Gülfe, Lars-Erik Kristensen, Johan K Wallman
Dive into the research topics of 'Patient-Reported Outcomes Are More Important Than Objective Inflammatory Markers for Sick Leave in Biologics-Treated Patients With Rheumatoid Arthritis'. Together they form a unique fingerprint.